Quest Diagnostics
DGX
#1090
Rank
โ‚น1.457 T
Marketcap
โ‚น13,056
Share price
1.04%
Change (1 day)
15.45%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2024 (TTM): โ‚น795.86 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is โ‚น813.48 Billion. In 2023 the company made a revenue of โ‚น770.21 Billion a decrease over the revenue in the year 2022 that were of โ‚น817.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น795.86 B3.33%
2023 โ‚น770.21 B-5.82%
2022 โ‚น817.81 B1.85%
2021 โ‚น802.96 B16.34%
2020 โ‚น690.16 B25.27%
2019 โ‚น550.94 B4.63%
2018 โ‚น526.58 B10.36%
2017 โ‚น477.15 B-6.56%
2016 โ‚น510.68 B2.56%
2015 โ‚น497.94 B5.67%
2014 โ‚น471.21 B6.73%
2013 โ‚น441.50 B10.51%
2012 โ‚น399.51 B0.56%
2011 โ‚น397.30 B20.32%
2010 โ‚น330.20 B-4.54%
2009 โ‚น345.92 B-0.72%
2008 โ‚น348.44 B32.42%
2007 โ‚น263.13 B-5.22%
2006 โ‚น277.63 B12.32%
2005 โ‚น247.18 B11.33%
2004 โ‚น222.02 B2.92%
2003 โ‚น215.71 B9.5%
2002 โ‚น196.99 B12.54%
2001 โ‚น175.04 B9.63%
2000 โ‚น159.67 B66.56%
1999 โ‚น95.86 B54.57%
1998 โ‚น62.01 B3.24%
1997 โ‚น60.07 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น1.084 T 33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.72 B-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น54.92 B-93.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.72 B-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.19 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น167.67 B-79.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands